(Press-News.org) MINNEAPOLIS, MN – May 1, 2014 – The Minneapolis Heart Institute Foundation (MHIF) announced today the first implant of the world's smallest pacemaker at the Minneapolis Heart Institute. The device was implanted as part of a global clinical trial and the procedure was the first of its kind in the Midwest.
One-tenth the size of a conventional pacemaker, and comparable in size to a large vitamin, the Medtronic Micra™ Transcatheter Pacing System is delivered directly into the heart through a catheter inserted in the femoral vein. Once positioned, the pacemaker is securely attached to the heart wall and can be repositioned or retrieved if needed. The miniature device does not require
the use of wires, known as "leads," to connect to the heart. Attached to the heart via small tines, the pacemaker delivers electrical impulses that pace the heart through an electrode at the end of
the device.
"This miniaturized technology is designed to provide patients with the advanced pacing technology of traditional pacemakers via a minimally invasive approach," said MHIF researcher
Dr. Charles Gornick, who implanted the pacemaker. "We are proud that MHIF was selected among an elite group of institutions to take part in this clinical trial. If positive, the results of the trial could potentially benefit many people globally who receive pacemakers each year." In contrast to current pacemaker implant procedures, the miniature pacemaker does not require a surgical incision in the chest and the creation of a "pocket" under the skin. This eliminates a potential source of complications, and any visible sign of the device.
INFORMATION:
About the Minneapolis Heart Institute Foundation
The Minneapolis Heart Institute Foundation is dedicated to improving people's lives through the highest quality cardiovascular research and education.
Scientific Innovation and Research — Publishing more than 120 peer-reviewed studies each year, MHIF is a recognized research leader in the broadest range of cardiovascular medicine. Each year, cardiologists and hospitals around the world adopt MHIF protocols to save lives and improve patient care.
Education and Outreach — Research shows that modifying specific health behaviors can significantly reduce the risk of developing heart disease. Through community programs, screenings and presentations, MHIF educates people of all walks of life about heart health. The goal of the Foundation's community outreach is to increase personal awareness of risk factors and provide the tools necessary to help people pursue heart- healthy lifestyles.
About the Minneapolis Heart Institute®
The Minneapolis Heart Institute® is recognized internationally as one of the world's leading providers of heart and vascular care. This state-of-the-art facility combines the finest in personalized patient care with sophisticated technology in a unique, family-oriented environment. The Institute's programs, a number of which are conducted in conjunction with Abbott Northwestern Hospital, address the full range of heart and vascular health needs:
prevention, diagnosis, treatment and rehabilitation.
Contact:
Jackie Boucher
Minneapolis Heart Institute Foundation
612-863-1636
jboucher@mhif.org
http://www.mplsheart.org
Minneapolis Heart Institute Foundation implants its 1st world's smallest cardiac pacemaker
2014-05-05
[Attachments] See images for this press release:
ELSE PRESS RELEASES FROM THIS DATE:
Penn study shows stimulant drug may help women cope with post-menopausal memory lapses
2014-05-05
NEW YORK – Menopausal women have long reported experiencing hot flashes, mood swings, night sweats and memory lapses, too.
A new study from researchers in the Perelman School of Medicine at the University of Pennsylvania shows preliminary evidence that the psychostimulant drug lisdexamfetamine (LDX) can aid post-menopausal women by improving attention and concentration, organization, working memory and recall. The findings will be presented by C. Neil Epperson, MD, director of the Penn Center for Women's Behavioral Wellness, on Tuesday during the American Psychiatric ...
Inbred wolves struggle, moose proliferate at Isle Royale National Park
2014-05-05
During their annual Winter Study at Isle Royale National Park, scientists from Michigan Technological University counted nine wolves organized into one breeding pack and a second small group that is a remnant of a formerly breeding pack.
In the Isle Royale Wolf-Moose Study’s annual report released today, the researchers say that over the past three years, they have tallied the lowest numbers of wolves ever: nine in 2011–12, eight in 2012–13 and nine in 2013–14. During the same period, predation rates—the proportion of the moose population killed by wolves—also dropped ...
Infusion of young blood recharges brains of old mice, Stanford study finds
2014-05-05
STANFORD, Calif. — Something — or some things — in the blood of young mice has the ability to restore mental capabilities in old mice, a new study by Stanford University School of Medicine investigators has found.
If the same goes for humans, it could spell a new paradigm for recharging our aging brains, and it might mean new therapeutic approaches for treating dementias such as Alzheimer's disease.
In the study, to be published online May 4 in Nature Medicine, the researchers used sophisticated techniques to pin down numerous important molecular, neuroanatomical and ...
Compound Formula Rehmannia alleviates dyskinesia in Parkinson's disease
2014-05-05
Levodopa is the preferred treatment for Parkinson's disease in the clinic. However, long-term use of levodopa may lead to various motor complications, among which levodopa-induced dyskinesia is the most common, severely affecting patients' quality of life. Dr. Jiancheng He and co-workers from Shanghai University of Traditional Chinese Medicine in China established a model of Parkinson's disease dyskinesia in rats, and treated these animals with Compound Formula Rehmannia. They found that Compound Formula Rehmannia alleviates levodopa-induced dyskinesia in Parkinson's disease ...
New idea for hearing improvement in patients with hearing aids under background noise
2014-05-05
Patients with implanted artificial cochlea often complain that they cannot recognize speech well in natural environments, especially if background of noise is present. Researchers think that a poor ability to localize sound in a complex auditory environment is responsible for the weak speech perception observed under these conditions. Pentobarbital anesthesia prolongs the recovery time of responses to lagging stimulus. The effects of pentobarbital anesthesia on the precedence effect stem from decreased dissociation of gamma-aminobutyric acid from its receptor (i.e., it ...
When highest perceptual ability occurs in a day?
2014-05-05
Many previous chronobiological studies have reported on detection of circadian fluctuation in performing simple motor tasks, fine skilled movement, and anaerobic exercise. However, to the best of our knowledge, literature concerning variation of sensory function according to the circadian cycle is lacking. Therefore, Yong Hyun Kwon and co-workers from Yeungnam University College of Science and Technology in Republic of Korea observed and compared the circadian fluctuations in tactile sense, joint reposition sense and two-point discrimination in 21healthy adult subjects ...
PQ disconnection with the activity of isolated PTO nerve tissue for seizure control
2014-05-05
Diffuse lesions involving the posterior quadrant (PQ) of the cerebral hemisphere (temporal, parietal, and occipital lobes) induce intractable epilepsy. These patients are potential candidates for surgical treatment. Maintenance of isolated nerve tissue activity after surgery plays a crucial role in the neuroprotective effects of neurosurgery treatment. Shaoya Yin and colleagues from Tianjin Huanhu Hospital in China selected two patients with temporal-parietal-occipital (PTO) intractable epilepsy to receive posterior quadrant disconnection. Postoperative MRI scans of the ...
A first: Nuclear transfer to reprogram adult patient cells into stem cells
2014-05-05
Jerusalem, May 4, 2014 -- The capacity to reprogram adult patient cells into pluripotent, embryonic-like, stem cells by nuclear transfer has been reported as a breakthrough by scientists from the US and the Hebrew University of Jerusalem.
The work, described in the journal Nature, was accomplished by researchers from the New York Stem Cell Foundation Research Institute and Columbia University and by Nissim Benvenisty, the Herbert Cohn professor of Cancer Research and director of the Stem Cell Unit at the Institute of Life Sciences at the Hebrew University of Jerusalem, ...
Glutamine ratio is key ovarian cancer indicator
2014-05-05
HOUSTON -- (May 5, 2014) -- A Rice University-led analysis of the metabolic profiles of hundreds of ovarian tumors has revealed a new test to determine whether ovarian cancer cells have the potential to metastasize, or spread to other parts of the body. The study also suggests how ovarian cancer treatments can be tailored based on the metabolic profile of a particular tumor.
The research, which appears online this week in Molecular Systems Biology, was conducted at the Texas Medical Center in Houston by researchers from Rice, the University of Texas MD Anderson Cancer ...
New technique tracks proteins in single HIV particle
2014-05-05
An interdisciplinary team of scientists from KU Leuven in Belgium has developed a new technique to examine how proteins interact with each other at the level of a single HIV viral particle. The technique allows scientists to study the life-threatening virus in detail and makes screening potential anti-HIV drugs quicker and more efficient. The technique can also be used to study other diseases.
Understanding how the human immunodeficiency virus (HIV) reproduces itself is crucial in the effort to fight the disease. Upon entering the bloodstream, HIV viral particles, or ...